Patent · US Active

Compound having effects of inhibiting phosphodiesterase 4, preparation method thereof and pharmaceutical use thereof

US11161860B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 25, 2018
Grant dateNov 2, 2021
Priority date
Expiry dateDec 25, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F5/025
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure relates to the field of medicinal chemistry, in particular, to a class of small molecule compounds for inhibiting phosphodiesterase 4 (I), a preparation method thereof and a pharmaceutical composition comprising the compound. The pharmacodynamic test proves that the compound of the disclosure has the inhibitory activity of PDE-4 enzyme and the efficacy of inflammation treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.